Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins

  • A. King
  • C. Boothman
  • I. Phillips
New Antimicrobial Agents

Abstract

In in vitro tests the broad-spectrum cephalosporins cefpirome and cefepime were highly active againstEnterobacteriaceae, although often less so against strains resistant to amoxicillin-clavulanate and ticarcillin-clavulanate, and against most strains ofAcinetobacter spp. andAeromonas hydrophila. They were also active againstPseudomonas aeruginosa, although strains with non-plasmid mediated beta-lactam resistance were sometimes less sensitive. OtherPseudomonas spp. varied in their sensitivity. Both agents were highly active againstHaemophilus influenzae, but beta-lactamase-producingBranhamella catarrhalis were somewhat less sensitive.Neisseria gonorrhoeae were susceptible, although non-beta-lactamase producing penicillin-resistant strains had higher MICs.Gardnerella vaginalis was also susceptible andCampylobacter coli/jejuni usually susceptible. Both antibiotics had good activity againstStaphylococcus aureus and coagulase-negative staphylococci except for methicillin-resistant strains andStaphylococcus haemolyticus which were of borderline sensitivity. All streptococci were sensitive, with the exception of highly penicillin-resistant pneumococci and enterococci against which cefpirome had greater activity than cefepime. Both antibiotics had little useful activity against theBacteroides fragilis group orBacteroides oralis group but were active against most other anaerobes.Clostridium difficile and some otherClostridium species were resistant.

Keywords

Internal Medicine Cephalosporin Good Activity Great Activity Clostridium Difficile 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    King A, Warren C, Shannon K, Phillips I The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin. Journal of Antimicrobial Chemotherapy 1980, 6: 479–494.PubMedGoogle Scholar
  2. 2.
    Working Party of the British Society for Antimicrobial Chemotherapy Breakpoints in in vitro sensitivity testing. Journal of Antimicrobial Chemotherapy 1988, 21: 701–710.Google Scholar
  3. 3.
    Jones RN, Thornsberry C, Barry AL In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin. Antimicrobial Agents and Chemotherapy 1984, 25: 710–718.PubMedGoogle Scholar
  4. 4.
    Kessler RE, Biers M, Buck RE, Chisholm DR, Pursiano TA, Tsai YH, Misiek M, Price KE, Leitner F Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy 1985, 27: 207–216.PubMedGoogle Scholar
  5. 5.
    Neu HC, Chin NX, Labthavikul P The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci,Enterobacteriaceae andPseudomonas aeruginosa. Infection 1985, 13: 146–155.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1990

Authors and Affiliations

  • A. King
    • 1
  • C. Boothman
    • 1
  • I. Phillips
    • 1
  1. 1.Department of Microbiology, United Medical and Dental SchoolsSt. Thomas' HospitalLondonUK

Personalised recommendations